BioInnovation Institute

Showcasing the breadth of impact in BII’s portfolio to The Royal House👑 Today, HM King Frederik X visited BII to experience our refurbished domicile and get a glimpse of the innovation of tomorrow.🔮 Throughout his visit, HM King Frederik X met four start-ups, each pioneering impact-driven solutions within their respective fields of biomaterials, quantum communication, women’s health and metabolic health. Visibuilt pioneers sustainable road construction by replacing substances from the fossil fuel industry with earth-friendly materials. Alea Quantum Technologies produces the world’s fastest quantum random number generators to allow secure and encrypted communication. oasicare has developed a game-changing solution to support midwives in their effort to reduce perineal tears during birth. Ousia Pharma develops novel peptide-drug conjugates for the treatment of cognitive disorders and metabolic diseases.  These four phenomenal start-ups illustrated the capacity the BII start-up community holds and the important work BII does to Bring science to life.   Thank you for visiting, HM King Frederik X. We hope to see you again soon to show you even more remarkable innovations.    Jens Nielsen Pui Ling Lau Marianne Philip Line Kloster Pedersen, Oleksii Rebrov, Sam Garrett, Asger Trier Bing, Hannes Lindal, Eric Jurgensen Geraci, Ditte Marie Fog Ibsen, Julia Sand, Charlotte Widén, Anders Bue Klein, Jonas Odgaard Petersen 

We have a goal– to bring science to life 💭 Yesterday we held the Grand Opening of our new domicile in the heart of Copenhagen. It was a joyous and inspiring day, allowing us to truly feel that the 250 participants share our dream to translate more groundbreaking research into life-changing innovation for the benefit of human health, planetary health and societal resilience. This building sets the stage for an ambitious new era, where we scale our activities in alignment with our strategic vision. We want to thank the architects, Tegnestuen Kontekst, for designing a building that embodies our vision, creating an open environment that invites collaboration and the sharing of knowledge and ideas as well as meeting the advanced technical and operational needs of our start-ups and projects. One of the building’s defining features is the atrium that stretches across our four floors creating an open and collaborative environment and naturally drawing one’s eyes towards the sky. So, when people enter our new home, they are reminded that the sky is the limit for what can be achieved at BII. With the official inauguration of our new domicile we look forward to welcoming many more startups and help them bring science to life.🚀 Jens Nielsen Marianne Philip Ministry of Higher Education and Science Ministry of Industry, Business and Financial Affairs Danish Centre for AI Innovation (DCAI) Novo Nordisk Foundation DTU - Technical University of Denmark Københavns Universitet - University of Copenhagen Aalborg University Aarhus University Syddansk Universitet - University of Southern Denmark

Today marks a new chapter in the history of BII🏢 Since BII was established in December 2017, we have supported more than one hundred start-ups that are tirelessly working to improve human health, planetary health and societal resilience for the benefit of society. Today we officially inaugurate our domicile here in Copenhagen, and the new building is yet another milestone for BII. Our new domicile is more than just a workspace – it's a vibrant hub where entrepreneurs, researchers, and experts can come together to exchange ideas, build networks, and push the boundaries of what is possible. The building serves as a physical frame for the visions to create a vibrant innovation hub in the heart of Copenhagen. But BII is just one actor in the innovation ecosystem, and only by collaborating with others can we solve the grand challenges of today and tomorrow. Thus, to celebrate the Grand Opening of our domicile, we have invited our many valued stakeholders and collaborators who stand with us on our mission to bring science to life. Jens Nielsen Morten Bødskov Christina Egelund Mads Krogsgaard Thomsen Nadia Carlsten, PhD Dina Petranovic PhD EMBA Novo Nordisk Foundation Københavns Universitet - University of Copenhagen DTU - Technical University of Denmark Syddansk Universitet - University of Southern Denmark Aarhus University Aalborg University Culture Works (DK) Katrine Villarreal Villumsen Anders Østerby Mønsted Line Rebien Tine Roland Presterud Lea Kynde Sigrid Hyldig

What does it take to create high-growth, successful life science companies with global ambitions? What’s the key to unlocking the massive potential in life science?🔐 One decisive factor is a high-performing board with sound corporate governance principles. That is why BioInnovation Institute and CBS Executive Fonden have come together to co-create a board education program based on knowledge and experience from the life science Industry and startup companies. The program will provide participants with models and tools regarding the board’s role, best practices, dilemmas, and challenges. 📅 Date: April 28-29, 2025  📍 Location: Porcelænshaven 22, 2000 Frederiksberg  ⏰ Deadline: 1 PM, March 17, 2025  Have a question? Reach out to Program Manager Jette Korsholm or Head of Onboarding Anette Clausen.  👉 Click here to read more and sign up: https://bit.ly/3QXLpov  Birgitte Nauntofte Bobby Soni Christian Schwenn Johansen Claus Elsborg Olesen Hans T. Schambye Henrijette Richter Inge Berneke Jens Nielsen John Haurum Kasim Kutay Martin Bonde Oliver Machholdt Steen Thomsen Sten Verland, PhD MSc Ulla Hald Buhl 

💜 Today, on International Women's Day, we proudly celebrate the incredible innovators working tirelessly to close the gap in women’s health and reproductive health 💜 At BioInnovation Institute (BII), we are committed to advancing women’s and reproductive health, and we recognize that society loses if we dismiss the health needs of 50% of the population ♀️ One of the shining examples of this commitment is oasicare. As part of BII’s Venture Lab program, Oasi.care has worked on tackling a critical gap in maternal health; improving birth outcomes by minimizing the risk of perineal tears, a critical issue that affects countless women globally 🤰 And this is not a one-off. At BII, we are proud to have supported 16 groundbreaking projects that address crucial issues in the realm of women’s health, such as: - Drug development targeting endometriosis - Maternal health issues such as preeclampsia and pregnancy loss - Male and female infertility - Accelerating diagnostics solutions in STIs, pregnancy, prenatal care and hypothyroidism - New treatments for systemic sclerosis and other diseases of inflammation and fibrosis - Non-hormonal contraception option for women 🔗 Watch the video below to learn more about how Oasi.care is changing the future of women’s health and how BII has supported the journey - or have a look at the other amazing projects supported by BII. Prenaital, Rapidemic, OvartiX, Pharmista Technologies, Sulis Therapeutics, Beech Biotech SA, Probmet Therapeutics, FimmCyte, Notify Therapeutics, XY Therapeutics, Cirqle Biomedical HEI Therapeutics Nima Life, CurE-me, Dawn Bio, Ditte Marie Fog Ibsen, Julia Sand, Charlotte Widén Johanna Roostalu Sanne Brun Jensen Angela Ibler

Celebrating graduates and new Venture House companies!🎉 We are excited to announce the four former Venture Lab start-ups that have made it into our Venture House Program! Congratulations to PreTT, oasicare, Cambiotics, and Alea Quantum Technologies, who will make up our sixth Venture House cohort. We are also glad to celebrate the graduating start-ups Agrobiomics, FimmCyte, HHC medical, Matr Foods, SOLID Therapeutics, and TriptoBIO, who have completed the program. The Venture House program is a follow-on funding- and support opportunity for start-ups that have already participated in our Venture Lab program. It aims to support product innovation and ecosystem growth through four executive sprints; each focused on a key development area to help mature the project and attract further funding.💸 CBO of BII Trine Bartholdy says: “The four companies align with BII’s mission to bring science to life by enabling ambitious and visionary founders to develop new solutions for the benefit of human health, planetary health, and societal resilience. So, we are proud to extend our support to these companies in the Venture House program with increased financial support and a tailored program to bring them closer to receiving external investment and commercializing their products and technologies.” Reflecting on the graduating cohort, Trine continues, “Their progress over the past 18 months has been remarkable. While it’s always bittersweet to see them move on, we look forward to following their continued journey.”🚀

✨ Reflecting on an incredible day at the Women's Health Investor Summit 2025! ✨ Yesterday was a full house at BII! Thought leaders, investors, start-ups, and industry came together to ignite a conversation about the future of women's health. The event, co-hosted by BioInnovation Institute, Angella Invest, Organon, and Nordic Women's Health Hub, brought together innovative minds with a shared goal: accelerating investments in women’s health and reproductive health. The need for investment in this space is more critical than ever. And the message was clear: By empowering start-ups, fostering collaborations, and ensuring funding, we can drive the change this sector desperately needs. We are grateful to the distinguished speakers and panelists who shared their insights, including: 🔸 Sanne Brun Jensen, BioInnovation Institute – on supporting early-stage women’s health start-ups  🔸 Diana Torgersen, Organon – on the role of investors and industry in shaping the future of women’s health 🔸 Triin Linamagi, Sie Ventures – on the growth potential of women’s health investments in Europe 🔸 Malin Frithiofsson, Daya – on accelerating investment in women’s health 🔸 Tommy Andersen, byFounders – on early-stage investment opportunities 🔸 Malene Enø, Nordic Women's Health Hub – for skillful moderation of the panel discussion 🔸Kristine Leerbeck, Angella Invest – for taking us through the program A huge thanks to all the start-ups that presented us with their amazing products and solutions: Cure-me, oasicare, OvartiX, Pharmista Technologies, Prenaital, XY Therapeutics, Uvisa Health, MammaGO, Sylvia Health, MagCath, LEIA Health, and Mewalii. We’re excited to continue supporting this journey and watching the ideas grow into impactful solutions 🔥 Johanna Roostalu Trine Bartholdy Angela Ibler Cathrine Nygaard Christensen Umar Adegoke Matthias Wulf Christian Hebel, MD Tony Cheng-Fu Chang Maj Hedtjärn Per Barfod Andersen

We are glad to share the February edition of the BII Start-up Stories newsletter.📬 Although February is the shortest month of the year, our start-ups have certainly taken full advantage of the limited days at their disposal. Among the news in the month's digest are a working agreement with the Dutch government, a cool media clip in Forbes, and the release of the world's first quantum large language model.🚀 Sounds interesting?👀 Dig in below!

𝐎𝐩𝐞𝐧 𝐜𝐚𝐥𝐥 𝐟𝐨𝐫 𝐁𝐈𝐈'𝐬 𝐁𝐢𝐨 𝐒𝐭𝐮𝐝𝐢𝐨 𝐩𝐫𝐨𝐠𝐫𝐚𝐦 in Brain Health 🧠📢 We are excited to announce an open call for our company creation program, Bio Studio. 👏 BII's Bio Studio program supports world-leading scientists in translating academic research into innovative products and solutions. In this open call, we seek applications in Brain Health, particularly for those targeting novel biological mechanisms to develop new therapeutic solutions for neuro-rare diseases. The call is jointly supported by BII and BII’s Innovation Partner H. Lundbeck A/S.   📅 Deadline for Expression of Interest: May 8 💸 Funding: an in-kind grant of up to 1M EUR/year  ⏰Project duration: up to 3 years 🏢 You will get access to BII state-of-the-art facilities in central Copenhagen   You can find guidelines and more specific information on the current call here: https://bit.ly/3vFt6LA   Lundbeck Jesper F. Bastlund Markus Herrgård Trine Bartholdy Sanne Brun Jensen Umar Adegoke Shivani Joshi, Ph.D. Jakob Pallesen Anne Steinø Matthias Wulf Johanna Roostalu Angela Ibler Katja Brunner Taylor R. Cooney Sofie Singbrant Söderberg Iben Egebæk Nikolajsen Anders Østerby Mønsted   #companycreation #funding #innovation #entrepreneurship #brainhealth #lifescience #neurorarediseases

ARE YOU READY? 💥Introducing Venture Lab cohort 8!💥  The time has finally come: We’re thrilled to introduce you to Venture Lab cohort 8🚀    💊💉In human health, we welcome Synuca Therapeutics, Incipiam Pharma, Beech Biotech SA, Akasi Pharma, Proxi Biotech, 3Sonic, Xterna and Navira.    🌍🌱In planetary health, we welcome NanoGuard Crop Solutions, Gefjon Pharma, microMINER, and Cerelixis.  That’s enough from us. After all, the video speaks for itself.🎬   Welcome to our community Odd Erik Hansen, Celia M., Kenneth Veland Halberg, Ph.D., Eva Maria Rebrova, Iciar de la Fuente Galiano, Marianna Vrettou-Schultes, Lasse Reimer, Tora Henriksen, Casper Tind Hansen, Mads Tang-Christensen, Tobias Todsen, Fatemeh Makouei, Christian Primdahl, Torben Hald, Thomas Buthler, Karl Dietrich Brune, Jessica Corry, Ian Cottingham, René Jørgensen, Aria Aminzadeh, Walden Emil Bjørn-Yoshimoto, Anders Miki Bojesen, Fabio Antenucci, Sophie Heiden Laugesen, Helena Safavi and many more!